Innovation, Science and Industry Minister Francois-Philippe Champagne has been in Japan for the past week, pitching Canada as a good location for production of electric vehicles and the batteries that power them.
While meeting with the presidents of Mitsubishi Tanabe Pharma and Mitsubishi Chemical, which owns a 79 per cent stake in Medicago, Champagne says there were discussions about the company’s future as a global vaccine manufacturer. Its biopharmaceutical vaccine has been rejected by the WHO because tobacco company Philip Morris is a minority shareholder, and the UN agency has a strict policy about engagement with the tobacco industry.
The Covifenz vaccine was licensed by Health Canada in February for adults aged 18 to 64, and the federal government has signed a contract to buy up to 76 million doses with plans to donate vaccines to low-income countries.Article contentChampagne says the government is working with the company to make Medicago “a global leader when it comes to global health.
Colombia Últimas Noticias, Colombia Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Fuente: globeandmail - 🏆 5. / 92 Leer más »
Fuente: CTVNews - 🏆 1. / 99 Leer más »
Fuente: TerraceStandard - 🏆 24. / 68 Leer más »